France's Sanofi has agreed to buy U.S.-based Blueprint Medicines Corporation for up to $9.5 billion to boost its position in ...

PARIS (Reuters) -French pharma group Sanofi has agreed to buy US-based Blueprint Medicines Corporation, a biopharmaceutical ...

The chairman of Hong Kong Exchanges and Clearing (HKEX) sold a house in Pok Fu Lam for HK$70 million (US$8.9 million), around three times what he paid for it a quarter of a century ago ...

Good morning. Morgan Stanley sees the US dollar weakening another 9% in the year ahead. Ukrainian drones hit as far as ...

U.S. liquefied natural gas output fell in May due to plant outages and maintenance at the country's largest export facility, ...

Shares rose early Tuesday in Asia after US stock indexes drifted closer to records, while oil prices extended gains.

Sanofi will buy the US maker of the world’s only approved treatment for a debilitating rare blood disorder for up to $9.5bn, as it seeks to boost its immunology medicine pipeline.

British investment firm Rosebank Industries said on Monday it has restarted talks to buy U.S.-based Electrical Components International, which makes wire harnesses, for under $1.9 billion.

US President Donald Trump has set a deadline of July 9 for countries to avoid sweeping tariffs. Lutnick said that he was a ...

New research suggests that removing fluoride from public water would increase dental care costs and tooth decay for children ...

Shares rose early Tuesday in Asia after U.S. stock indexes drifted closer to records, while oil prices extended gains.

Follow live reaction from Paris after Sinner won the final match of the day to follow Gauff, Keys and Djokovic into the ...